Wiel Geraedts

1.9k total citations
34 papers, 1.4k citations indexed

About

Wiel Geraedts is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, Wiel Geraedts has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Radiation. Recurrent topics in Wiel Geraedts's work include Lung Cancer Diagnosis and Treatment (24 papers), Lung Cancer Treatments and Mutations (14 papers) and Advanced Radiotherapy Techniques (9 papers). Wiel Geraedts is often cited by papers focused on Lung Cancer Diagnosis and Treatment (24 papers), Lung Cancer Treatments and Mutations (14 papers) and Advanced Radiotherapy Techniques (9 papers). Wiel Geraedts collaborates with scholars based in Netherlands, United States and Belgium. Wiel Geraedts's co-authors include Cordula Pitz, Philippe Lambin, Gerben Bootsma, Anne‐Marie C. Dingemans, Dirk De Ruysscher, Rinus Wanders, Jean Simons, Angela van Baardwijk, Liesbeth Boersma and Jacques Borger and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Wiel Geraedts

33 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wiel Geraedts Netherlands	18	1.1k	539	410	396	155	34	1.4k
Cordula Pitz Netherlands	25	1.5k 1.4×	592 1.1×	653 1.6×	421 1.1×	188 1.2×	44	1.8k
Sara Ramella Italy	22	1.7k 1.6×	937 1.7×	648 1.6×	694 1.8×	144 0.9×	136	2.4k
Gary W. Chmielewski United States	20	1.1k 1.0×	334 0.6×	253 0.6×	262 0.7×	29 0.2×	47	1.4k
Jason Pantarotto Canada	14	692 0.6×	350 0.6×	459 1.1×	426 1.1×	262 1.7×	45	1.2k
Adalsteinn Gunnlaugsson Sweden	19	952 0.9×	575 1.1×	191 0.5×	885 2.2×	44 0.3×	51	1.5k
William B. Fisher United States	17	846 0.8×	86 0.2×	760 1.9×	82 0.2×	160 1.0×	39	1.2k
Pia Baumann Sweden	14	1.3k 1.2×	616 1.1×	321 0.8×	824 2.1×	20 0.1×	29	1.7k
Bin Hwangbo South Korea	19	1.2k 1.1×	203 0.4×	175 0.4×	81 0.2×	120 0.8×	47	1.5k
Alison M. Shippy United States	12	1.6k 1.5×	324 0.6×	183 0.4×	1.1k 2.7×	43 0.3×	17	1.9k
Alexandra Stewart United Kingdom	20	430 0.4×	250 0.5×	264 0.6×	368 0.9×	92 0.6×	67	1.1k

Countries citing papers authored by Wiel Geraedts

Since Specialization

Citations

This map shows the geographic impact of Wiel Geraedts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wiel Geraedts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wiel Geraedts more than expected).

Fields of papers citing papers by Wiel Geraedts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wiel Geraedts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wiel Geraedts. The network helps show where Wiel Geraedts may publish in the future.

Co-authorship network of co-authors of Wiel Geraedts

This figure shows the co-authorship network connecting the top 25 collaborators of Wiel Geraedts. A scholar is included among the top collaborators of Wiel Geraedts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wiel Geraedts. Wiel Geraedts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reymen, Bart, Angela van Baardwijk, Rinus Wanders, et al.. (2014). Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR). Radiotherapy and Oncology. 110(3). 482–487. 19 indexed citations

Reymen, Bart, Judith van Loon, Angela van Baardwijk, et al.. (2012). Total Gross Tumor Volume Is an Independent Prognostic Factor in Patients Treated With Selective Nodal Irradiation for Stage I to III Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1319–1324. 34 indexed citations

Steevens, Jessie, Dirk De Ruysscher, Anita A.M. Botterweck, et al.. (2011). Also elderly patients (75 years or older) with stage III non-small cell lung cancer (nsclc) have survival gains with radical treatment: a prospective population-based study. Journal of Thoracic Oncology. 6(6). 1 indexed citations

Baardwijk, Angela van, Bart Reymen, Rinus Wanders, et al.. (2011). Results of a phase II trial on individualized radiation dose-escalation based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 6(6).

Ruysscher, Dirk De, Angela van Baardwijk, Jessie Steevens, et al.. (2011). Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study. Radiotherapy and Oncology. 102(2). 228–233. 39 indexed citations

Loon, Judith van, Dirk De Ruysscher, Rinus Wanders, et al.. (2009). Selective Nodal Irradiation on Basis of 18FDG-PET Scans in Limited-Disease Small-Cell Lung Cancer: A Prospective Study. International Journal of Radiation Oncology*Biology*Physics. 77(2). 329–336. 111 indexed citations

Baardwijk, Angela van, Bart Reymen, Rinus Wanders, et al.. (2009). Individualized radiation dose escalation for stage I-III non-small cell lung cancer (NSCLC) based on normal tissue constraints: mature results of a phase II trial. Journal of Thoracic Oncology. 4(9). 1 indexed citations

Loon, Judith van, Janneke P.C. Grutters, Rinus Wanders, et al.. (2009). 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: An economic evaluation. European Journal of Cancer. 46(1). 110–119. 36 indexed citations

Aerts, Hugo J.W.L., Steven Petit, Judith van Loon, et al.. (2009). Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan. Radiotherapy and Oncology. 91(3). 386–392. 151 indexed citations

10.

Baardwijk, Angela van, Geert Bosmans, Liesbeth Boersma, et al.. (2008). Individualized Radical Radiotherapy of Non–Small-Cell Lung Cancer Based on Normal Tissue Dose Constraints: A Feasibility Study. International Journal of Radiation Oncology*Biology*Physics. 71(5). 1394–1401. 56 indexed citations

11.

Ruysscher, Dirk De, Anita A.M. Botterweck, Miranda J.M. Dirx, et al.. (2008). Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Annals of Oncology. 20(1). 98–102. 143 indexed citations

12.

Ruysscher, Dirk De, Rinus Wanders, Monique Hochstenbag, et al.. (2007). HI-CHART: A Phase I/II Study on the Feasibility of High-Dose Continuous Hyperfractionated Accelerated Radiotherapy in Patients With Inoperable Non–Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 71(1). 132–138. 31 indexed citations

13.

Oberije, Cary, Dirk De Ruysscher, Hiska L. van der Weide, et al.. (2007). Tumor Volume Combined With Number of Positive Lymph Node Stations Is a More Important Prognostic Factor Than TNM Stage for Survival of Non–Small-Cell Lung Cancer Patients Treated With (Chemo)radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 70(4). 1039–1044. 87 indexed citations

14.

Ruysscher, Dirk De, C. Dehing, Søren M. Bentzen, et al.. (2007). Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Annals of Oncology. 18(5). 909–916. 40 indexed citations

15.

Ruysscher, Dirk De, S. Wanders, M. Hochstenbag, et al.. (2004). Selective mediastinal node irradiation on basis of the FDG-PET scan in patients with NSCLC is safe: results of a prospective clinical study. Radiotherapy and Oncology. 73. 1 indexed citations

16.

Geraedts, Wiel, et al.. (1993). Agenesis of the Right Upper Lobe. CHEST Journal. 103(5). 1612–1614. 4 indexed citations

17.

Davies, Benjamin, et al.. (1992). Clinical and bacteriological experience with cefodizime in acute purulent exacerbations of chronic bronchitis. Infection. 20(S1). S22–S25. 2 indexed citations

18.

Maesen, F. P. V., et al.. (1990). Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients. Journal of Antimicrobial Chemotherapy. 25(3). 413–422. 11 indexed citations

19.

Maesen, F. P. V., et al.. (1987). Penetration of Ofloxacin from Blood to Sputum. Drugs. 34(Supplement 1). 26–32. 14 indexed citations

20.

Maesen, F. P. V., et al.. (1987). The Use of Quinolones in Respiratory Tract Infections. Drugs. 34(Supplement 1). 74–79. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact